U-Neuron Biomedical (ROCO:6973) Accounts Payable: NT$1.37 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
12 GF Score
Price NT$36.65
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Accounts Payable?

U-Neuron Biomedical ROCO:6973 +0.69% 12 Accounts Payable is NT$1.37 Mil as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

U-Neuron Biomedical's Accounts Payable for the quarter that ended in Dec. 2025 was NT$1.37 Mil.

U-Neuron Biomedical's quarterly Accounts Payable increased from Dec. 2024 (NT$2.05 Mil) to Jun. 2025 (NT$3.02 Mil) but then declined from Jun. 2025 (NT$3.02 Mil) to Dec. 2025 (NT$1.37 Mil).

U-Neuron Biomedical's annual Accounts Payable declined from Dec. 2023 (NT$2.33 Mil) to Dec. 2024 (NT$2.05 Mil) and declined from Dec. 2024 (NT$2.05 Mil) to Dec. 2025 (NT$1.37 Mil).

U-Neuron Biomedical Accounts Payable Related Terms

U-Neuron Biomedical Accounts Payable Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Accounts Payable Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.70 2.60 2.33 2.05 1.37

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 2.62 2.05 3.02 1.37
ROCO:6973
12GF Score
U-Neuron Biomedical Inc ROCO:6973
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$1.37 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Accounts Payable of NT$1.37 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Accounts Payable too high?
U-Neuron Biomedical's current Accounts Payable is NT$1.37 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Accounts Payable compare to VRTX and REGN?
U-Neuron Biomedical's Accounts Payable of NT$1.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Accounts Payable is NT$1.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Accounts Payable of NT$1.37 Mil. The current Accounts Payable is NT$1.37 Mil. U-Neuron Biomedical's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Accounts Payable is NT$1.37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
12GF Score

Get the complete analysis for ROCO:6973

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$36.65
Price